Gemcitabine for the treatment of advanced nonsmall cell lung cancer
about
Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence.Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cellsRole of integrin-linked kinase in drug resistance of lung cancer.MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?RRM1 expression and the clinicopathological characteristics of patients with non-small cell lung cancer treated with gemcitabine
P2860
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
@ast
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
@en
type
label
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
@ast
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
@en
prefLabel
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
@ast
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
@en
P2860
P1476
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
@en
P2093
Federico Cappuzzo
Luca Toschi
P2860
P304
P407
P577
2009-02-18T00:00:00Z